These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18998325)

  • 1. Romanian anti-TB drugs resistance surveillance 2003-2004.
    Stoicescu IP; Homorodean D; Chiotan D; Moldovan O; Diculencu D; Popa C; Macri A; Husar I; Diţiu L; Aziz MA; Hoffner S
    Pneumologia; 2008; 57(3):131-7. PubMed ID: 18998325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
    Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
    Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tuberculosis drug resistance in Portugal.
    Antunes ML; Aleixo-Dias J; Antunes AF; Pereira MF; Raymundo E; Rodrigues MF
    Int J Tuberc Lung Dis; 2000 Mar; 4(3):223-31. PubMed ID: 10751067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of drug resistance in pulmonary tuberculosis cases in the Izmir district, Turkey.
    Tatar D; Senol G; Cosar D; Ozacar R; Halilcolar H
    New Microbiol; 2009 Jan; 32(1):31-7. PubMed ID: 19382667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
    Laszlo A; Rahman M; Espinal M; Raviglione M;
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):748-56. PubMed ID: 12234129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda.
    Umubyeyi AN; Vandebriel G; Gasana M; Basinga P; Zawadi JP; Gatabazi J; Pauwels P; Nzabintwali F; Nyiramasarabwe L; Fissette K; Rigouts L; Struelens MJ; Portaels F
    Int J Tuberc Lung Dis; 2007 Feb; 11(2):189-94. PubMed ID: 17263290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.
    Al-Hajoj S; Varghese B; Shoukri MM; Al-Omari R; Al-Herbwai M; Alrabiah F; Alrajhi AA; Abuljadayel N; Al-Thawadi S; Zumla A; Zignol M; Raviglione MC; Memish Z
    Antimicrob Agents Chemother; 2013 May; 57(5):2161-6. PubMed ID: 23459478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of proportion method in Löwenstein-Jensen medium with the BACTEC 460 TB system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis isolates].
    Gül Yurtsever S; Biçmen C; Gündüz AT; Ozkütük N; Salman S; Demirci M
    Mikrobiyol Bul; 2011 Oct; 45(4):623-31. PubMed ID: 22090293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
    El-Sayed Zaki M; Goda T
    Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
    Lu PL; Lee YW; Peng CF; Tsai JJ; Chen YH; Hwang KP; Chen TP
    Int J Antimicrob Agents; 2003 Mar; 21(3):239-43. PubMed ID: 12636985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
    Med Clin (Barc); 1996 Jan; 106(1):1-6. PubMed ID: 8750533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample survey of drug-resistant tuberculosis in Henan, China, 1996.
    Wang G; Peng YL; Zhang G; Zhang L; Xing J; Li D; Wang L; Song H; Ding D; Duanmu HJ; Zhang Z; Zhang G
    Respirology; 2002 Mar; 7(1):67-72. PubMed ID: 11896904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance of Mycobacterium tuberculosis strains isolated from HIV-infected Italian patients: preliminary report from a multicentric study. The Italian Tuberculosis Drug Resistance Study Group.
    Angarano G; Carbonara D; Costa D
    New Microbiol; 1995 Jan; 18(1):69-72. PubMed ID: 7760759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High initial and acquired drug resistance in pulmonary tuberculosis in Turkey.
    Tahaoğlu K; Kizkin O; Karagöz T; Tor M; Partal M; Sadoğlu T
    Tuber Lung Dis; 1994 Oct; 75(5):324-8. PubMed ID: 7841424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiopia.
    Demissie M; Gebeyehu M; Berhane Y
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):64-7. PubMed ID: 9441061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.